SEC Form 4 · accession 0001179110-17-009627
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Oyler
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 22, 2017
Accepted (ET)
Jun 26, 2017 · 8:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F3 | Jun 22, 2017 | S | 56,805 | $44.057 | D | 88,535 | D | |
| American Depositary SharesF1,F4 | Jun 22, 2017 | S | 1,800 | $44.7839 | D | 86,735 | D | |
| American Depositary SharesF1,F5 | Jun 23, 2017 | S | 24,414 | $43.8505 | D | 62,321 | D | |
| American Depositary SharesF1,F6 | Jun 23, 2017 | S | 10,981 | $44.6226 | D | 51,340 | D | |
| American Depositary SharesF1,F7 | Jun 23, 2017 | S | 4,500 | $45.7302 | D | 46,840 | D | |
| Ordinary Shares | holding | — | — | — | 23,473,805 | D | ||
| Ordinary SharesF8 | holding | — | — | — | 29,890,174 | I | See Footnote | |
| Ordinary SharesF9 | holding | — | — | — | 10,000,000 | I | See Footnote | |
| Ordinary SharesF10 | holding | — | — | — | 102,188 | I | See Footnote | |
| Ordinary SharesF11 | holding | — | — | — | 7,962,663 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F10These securities are held by The John Oyler Legacy Trust, of which the Reporting Person's father is a trustee, for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
- F11These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F2The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.50 to $44.48, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.65 to $44.80, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.08 to $44.07, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.27 to $45.23, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F7The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.29 to $46.00, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F8These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F9These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
Remarks
Exhibit 24 - Power of Attorney